Is Pazopanib available from Qilu Pharmaceutical?

Pazopanib (Pazopanib) There is a domestic drug produced by Qilu Pharmaceutical, which has been approved for marketing by the State Food and Drug Administration. Its drug ingredients are basically the same as those of the original drug of pazopanib, and the price of each box may be more than 2,000 yuan. Pazopanib is a targeted cancer drug, a treatment for advanced kidney cancer and certain types of advanced soft tissue sarcoma.

The targeted cancer drug pazopanib is also known as a tyrosine kinase inhibitor (TKI). Tyrosine kinases are proteins that act as chemical messengers (enzymes) in cells. There are many different tyrosine kinases that stimulate cancer cell growth. Pazopanib works by blocking many of these proteins, called polytyrosine kinase inhibitors (polyTKIs), which prevents cancer cells from forming the blood vessels they need to grow, which is called an anti-angiogenic treatment. Patients usually need blood tests before and during treatment with pazopanib. Doctors will check the levels of blood cells and other substances in the blood, as well as how well the liver and kidneys are working.

PazopanibThe original drug has been launched in China and has entered the scope of Class B medical insurance, but reimbursement is limited to patients who meet the indications. The price of each box may be around 3,000 yuan. The price of pazopanib original drug specifications200mg*30 tablets marketed overseas may be around 1,000 RMB per box (the price may fluctuate due to exchange rates). There are also pazopanib generic drugs produced in other countries. The price of 200mg*30 tablets produced by Bangladesh pharmaceutical factory may be around 500 yuan per box (the price may fluctuate due to the exchange rate), which is cheaper. The pharmaceutical ingredients of generic drugs are basically the same as those of domestic and foreign original drugs.